You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroendocrine hepatic tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumor, Liver Metastases, Neuroendocrine Gastroenteropancreatic Tumour Trial in France (Positron emission

Recruiting
  • Neuroendocrine Tumor
  • +2 more
  • Positron emission tomography computed tomography (PET/CT) with Intra-hepatic (IAH) injection
  • +3 more
  • Bordeaux, France
  • +3 more
Nov 18, 2021

Advanced Solid Tumors With Neuroendocrine Differentiation Trial (surufatinib?serplulimab)

Not yet recruiting
  • Advanced Solid Tumors With Neuroendocrine Differentiation
  • (no location specified)
Nov 27, 2023

Imaging Features in Invasiveness and Prognosis of Pituitary

Recruiting
  • Pituitary Adenoma
  • Neuroendocrine Tumors
  • diagnosed and treated reasonably according to the clinical guidelines and clinical pathways
  • Guangzhou, Guangdong, China
    endocrinology department of the first affiliated hospital of Sun
Aug 24, 2023

Surufatinib in G3 Neuroendocrine Tumors

Not yet recruiting
  • Neuroendocrine Tumor Grade 3
  • (no location specified)
Aug 2, 2023

Neuroendocrine Tumors Trial in Beijing (Surufatinib Combined With Temozolomide and S-1)

Not yet recruiting
  • Neuroendocrine Tumors
  • Surufatinib Combined With Temozolomide and S-1
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 8, 2023

Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • +6 more
  • (no location specified)
Aug 4, 2023

Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Neuroendocrine Carcinomas
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 22, 2023

Clinical Relevance of Salvage Treatment for Colorectal

Completed
  • Rectal Neoplasms
  • Neuroendocrine Tumors
  • salvage treatment
  • (no location specified)
Nov 16, 2023

Multi-dimensional Fragmentomic Assay for Early Detection of

Not yet recruiting
  • Pancreatic Neuroendocrine Tumor
  • Fragmentomic profiles of plasma cfDNA
  • (no location specified)
Apr 27, 2023

Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

Not yet recruiting
  • Digestive System Neuroendocrine Tumor G1
  • +5 more
  • Tumor Debulking
  • +5 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 23, 2023

Neuroendocrine Tumors, Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Trial in New York (177Lu-DOTATATE)

Recruiting
  • Neuroendocrine Tumors
  • Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 19, 2023

Neuroendocrine Tumors Trial in Hyderabad (Endoscopic submucosal dissection, EFTR)

Recruiting
  • Neuroendocrine Tumors
  • Endoscopic submucosal dissection
  • EFTR
  • Hyderabad, Telangana, India
    Asian institute of Gastroenterology
Nov 11, 2023

Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)

Completed
  • Pancreatic Neuroendocrine Tumor G2
  • Octreotide LAR
  • (no location specified)
Oct 17, 2023

Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +4 more
  • Newport Beach, California
  • +2 more
Aug 16, 2023

Pancreatic Neuroendocrine Tumor, Pancreas Cancer Trial in Chicago (cytoreductive surgery, Lutathera - a small molecule used in

Not yet recruiting
  • Pancreatic Neuroendocrine Tumor
  • Pancreas Cancer
  • cytoreductive surgery
  • +2 more
  • Chicago, Illinois
    The University of Chicago
Nov 8, 2022

Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor Trial in Madison (Single Photon Emission Computed

Not yet recruiting
  • Neuroendocrine Tumors
  • Somatostatin Receptor-positive Neuroendocrine Tumor
  • Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin - Madison
Nov 2, 2023

Neuroendocrine Tumors, Well-Differentiated Neuroendocrine Carcinoma, High Grade Neuroendocrine Carcinoma, Any Site Trial in San

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Feb 17, 2023

Carcinoid Tumor, Metastatic Carcinoid Tumor, Neuroendocrine Tumor Trial in Buffalo, Columbus (Laboratory Biomarker Analysis,

Active, not recruiting
Has Results
  • Carcinoid Tumor
  • +2 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Buffalo, New York
  • +1 more
Nov 8, 2022

Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide,

Not yet recruiting
  • Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide
  • long-acting Octreotide.
  • (no location specified)
May 22, 2023

Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)

Not yet recruiting
  • Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • (no location specified)
Oct 16, 2023

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,

Recruiting
  • Neuroendocrine Tumors
  • +4 more
  • [212Pb] VMT-α-NET
  • [203Pb] VMT-α-NET SPECT/CT
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center at the University of Iowa
Nov 30, 2023

Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

Recruiting
  • Gastroenteropancreatico Tumors
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)

Recruiting
  • Neuroendocrine Tumors
  • Al18F-NOTA-LM3
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Sep 20, 2023

Neuroendocrine Neoplasms Including Adrenocortical Carcinoma

Recruiting
  • Neuroendocrine Tumors
  • Carcinoma, Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Neuroendocrine Tumors Trial in Lexington (Telotristat (Low-Dose), Telotristat (High-Dose))

    Recruiting
    • Neuroendocrine Tumors
    • Telotristat (Low-Dose)
    • Telotristat (High-Dose)
    • Lexington, Kentucky
      Markey Cancer Center
    Nov 10, 2022